These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 29627034)

  • 21. Validation of the French version of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).
    Maubeuge N; Deloire MSA; Brochet B; Ehrlé N; Charré-Morin J; Saubusse A; Ruet A;
    Mult Scler Relat Disord; 2021 Feb; 48():102692. PubMed ID: 33352358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Cambridge Neuropsychological Test Automated Battery (CANTAB) Versus the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) for the Assessment of Cognitive Function in Patients with Multiple Sclerosis.
    Talebi M; Majdi A; Kamari F; Sadigh-Eteghad S
    Mult Scler Relat Disord; 2020 Aug; 43():102172. PubMed ID: 32442887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incremental validity of brief and abbreviated neuropsychological tests toward predicting functional outcomes in multiple sclerosis.
    Grant JG; Rapport LJ; Darling R; Waldron-Perrine B; Bernitsas E
    Appl Neuropsychol Adult; 2023 Feb; ():1-11. PubMed ID: 36773023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validity and reliability of the Georgian-language brief international cognitive assessment for multiple sclerosis (BICAMS).
    Botchorishvili N; Shiukashvili N; Mikeladze N; Dzagnidze A; Mikava N; Tighashvili M; Janelidze M
    BMC Neurol; 2021 Jun; 21(1):218. PubMed ID: 34107913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brief international cognitive assessment for multiple sclerosis (BICAMS) cut-off scores for detecting cognitive impairment in multiple sclerosis.
    Artemiadis A; Bakirtzis C; Chatzittofis A; Christodoulides C; Nikolaou G; Boziki MK; Grigoriadis N
    Mult Scler Relat Disord; 2021 Apr; 49():102751. PubMed ID: 33465758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trail Making Test Could Predict Impairment in Cognitive Domains in Patients with Multiple Sclerosis: A Study of Diagnostic Accuracy.
    Kabiri S; Jameie M; Balali P; Adib Moradi S; Sanjari Moghaddam H; Aghamollaii V; Harirchian MH
    Arch Clin Neuropsychol; 2023 Jan; 38(1):37-48. PubMed ID: 35901460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) in the Italian population.
    Migliore S; Ghazaryan A; Simonelli I; Pasqualetti P; Landi D; Palmieri MG; Moffa F; Rinaldi P; Vernieri F; Filippi MM
    Neurol Sci; 2016 Aug; 37(8):1261-70. PubMed ID: 27095052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reliability and validity of the Arabic version of brief international cognitive assessment for multiple sclerosis in Egyptian pediatric multiple sclerosis patients.
    Abualhasan A; Naseer MA; Shalaby N; El-Jaafary SI; Farghaly M; Shehata HS; Doma ES; Al-Azayem SA
    Mult Scler Relat Disord; 2024 Feb; 82():105374. PubMed ID: 38134604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in the Russian Population.
    Evdoshenko E; Laskova K; Shumilina M; Nekrashevich E; Andreeva M; Neofidov N; Kalinin I; Nikitchenko D; Rogozina A; Kupaeva A; Bulanov I; Bakirtzis C; Grigoriadis N; Khachanova N; Davydovskaya M; Makshakov G
    J Int Neuropsychol Soc; 2022 May; 28(5):503-510. PubMed ID: 34132190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Brief International Cognitive Assessment in Multiple Sclerosis (BICAMS): Validation in Arabic and Lebanese Normative Values.
    Darwish H; Zeinoun P; Farran N; Ghusn H; Yamout B; Khoury SJ
    J Int Neuropsychol Soc; 2022 Jan; 28(1):94-103. PubMed ID: 33563350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-cultural Adaptation, Reliability, and Validity of the BICAMS in Brazil.
    Spedo CT; Frndak SE; Marques VD; Foss MP; Pereira DA; Carvalho Lde F; Guerreiro CT; Conde RM; Fusco T; Pereira AJ; Gaino SB; Garcia RB; Benedict RH; Barreira AA
    Clin Neuropsychol; 2015; 29(6):836-46. PubMed ID: 26513484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS.
    Strober L; Englert J; Munschauer F; Weinstock-Guttman B; Rao S; Benedict RH
    Mult Scler; 2009 Sep; 15(9):1077-84. PubMed ID: 19556311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validity of a multi-domain computerized cognitive assessment battery for patients with multiple sclerosis.
    Golan D; Wilken J; Doniger GM; Fratto T; Kane R; Srinivasan J; Zarif M; Bumstead B; Buhse M; Fafard L; Topalli I; Gudesblatt M
    Mult Scler Relat Disord; 2019 May; 30():154-162. PubMed ID: 30772674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in individuals with multiple sclerosis from Mexico.
    Valdivia-Tangarife ER; Morlett-Paredes A; Villaseñor-Cabrera T; Mireles-Ramírez MA; Cortés-Enríquez F; Macías-Islas MÁ
    Mult Scler Relat Disord; 2024 Mar; 83():105451. PubMed ID: 38245997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Normative values of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in an Arab population: Corrected for age, sex and education.
    Alboudi A; Hadid A; Ali AR; Alshaikh F; Aqleh H
    Mult Scler Relat Disord; 2020 Sep; 44():102305. PubMed ID: 32570183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The utility of regression-based norms in interpreting the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).
    Parmenter BA; Testa SM; Schretlen DJ; Weinstock-Guttman B; Benedict RH
    J Int Neuropsychol Soc; 2010 Jan; 16(1):6-16. PubMed ID: 19796441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Don't be late! Timely identification of cognitive impairment in people with multiple sclerosis: a study protocol.
    Waskowiak PT; de Jong BA; Uitdehaag BMJ; Saddal SRD; Aarts J; Roovers AAM; van Oirschot P; de Groot V; Schaafsma FG; van der Hiele K; Ruitenberg MFL; Schoonheim MM; Widdershoven GAM; van der Veen S; Schippers ECF; Klein M; Hulst HE;
    BMC Neurol; 2024 Jan; 24(1):26. PubMed ID: 38218777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) in the Portuguese population with multiple sclerosis.
    Sousa C; Rigueiro-Neves M; Miranda T; Alegria P; Vale J; Passos AM; Langdon D; Sá MJ
    BMC Neurol; 2018 Oct; 18(1):172. PubMed ID: 30332999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).
    Benedict RH; Cookfair D; Gavett R; Gunther M; Munschauer F; Garg N; Weinstock-Guttman B
    J Int Neuropsychol Soc; 2006 Jul; 12(4):549-58. PubMed ID: 16981607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive impairment in pediatric-onset multiple sclerosis is detected by the Brief International Cognitive Assessment for Multiple Sclerosis and computerized cognitive testing.
    Charvet LE; Shaw M; Frontario A; Langdon D; Krupp LB
    Mult Scler; 2018 Apr; 24(4):512-519. PubMed ID: 28322606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.